https://pipelinereview.com/Boston-Strategics-Corporation-Initiates-a-Phase-1-Clinical-Trial-of-the-Anti-cancer-Agent-FF-10501-for-FUJIFILM-in-Patients-with-Advanced-Hematologic-Malignancies/